Experts urge mandatory NAT testing for blood transfusion safety in India
Medical experts and thalassemia advocates are urging the Indian government to mandate nucleic acid amplification testing (NAT) for blood safety, create a national thalassemia control program, and revise Ayushman Bharat eligibility criteria to include thalassemia patients. They emphasize the vulnerability of thalassemia patients to transfusion-transmitted infections and the need for patient inclusion in policy-making.
